Moderna’s sales target cut is in sharp contrast to that of larger rival Pfizer Inc, which earlier this week raised its sales forecast for its COVID-19 shot.
Moderna struggles with COVID-19 vaccine ramp-up, cuts 2021 sales forecast
Moderna’s sales target cut is in sharp contrast to that of larger rival Pfizer Inc, which earlier this week raised its sales forecast for its COVID-19 shot.